The US Food and Drug Administration, FDA, has again postponed its deadline for responding to Eli Lilly's application for the authorization of Olumiant, which is an eczema treatment for adults.
Eli Lilly and Incyte, the two firms collaborating over the drug, have therefore announced that the FDA will not respond in line with its original deadline, which was the third quarter of this year. They have not revealed when they now expect a response.
Already a subscriber? Log in.
Read the whole article
Get access for 14 days for free.
No credit card is needed, and you will not be automatically signed up for a paid subscription after the free trial.
- Access all locked articles
- Receive our daily newsletters
- Access our app
Get full access for you and your coworkers.
Start a free company trial todayMore from MedWatch
CHMP to remove 100 generic medicines from market
Due to fraudulent clinical trials from a contract research organization, the EMA’s expert committee, the CHMP, is now suspending marketing approval authorizations for around 100 generic drugs on the market.
Germany orders 40,000 monkeypox vaccines from Bavarian Nordic
The German Minister for Health has revealed that the German state has ordered vaccines from Bavarian Nordic, as the country reports 5 cases of monkeypox.
New head of research at Astellas Gene Therapies: "Choosing the right indications is extra important"
Morten Søgaard is leaving Pfizer to join Astellas, where he will be in charge of 100 employees. Going from one of the world largest pharmaceutical firms to a considerably smaller one will be a challenge, he says.
Rumored purchase of GN Group could mean divestment of hearing aid division, says media
Inside Business has learned that a number of buyers might be looking to buy GN Store Nord stock while it’s cheap, with the plan to sell one division, GN Hearing, while keeping Audio.
EMA publishes new plan to support antibiotic development
Drug-resistant bacteria kill hundreds of thousands of people every year, and national regulatory forces across the world are now coming together to ensure a uniform approach to clinical trials for antibiotics.
Senior Manager, Clinical Trial Budget 
Biostatistician 
Cell Culture Scientist/Senior Scientist 
Account Manager 
Project Manager & Scrum Master 
Innovation Project Manager, Display Unit 
Laboratory technician for process development and clinical manufacturing 
KLIFO is looking for a Clinical Supply Manager for our Glostrup office 
Client Talent Acquisition Specialist 
Clinical Project Manager 
2 Sales Representatives and Product Specialists 
Director Global Engineering 
Nordic Medical Affairs Manager 
Senior Project Manager (GMP - Life Science)